Arboretum LifeSciences
Cambridge, MA-based molecular information company that combines AI and clinical genetic testing to bring genomic medicine to common diseases.
- Industry
- molecular information, genetic testing, precision medicine
- Location
- Cambridge, MA
- Website
- https://www.arboretum.bio
About
Arboretum LifeSciences was founded by leaders from the Broad Institute Data Sciences Platform. It provides clinical genetic testing and a research network to health systems, and helps drug developers find genomically defined patient groups for clinical trials in conditions such as cardiovascular, metabolic and neurodegenerative disease. Its first healthcare delivery partners are Advocate Health, Geisinger, Providence Healthcare and Cardiovascular Associates of America. The company is led by co-founder and CEO Anthony Philippakis, who is also a general partner at GV, and president Clare Bernard.
Funding history
| Round | Date | Amount | Lead |
|---|---|---|---|
| Series A 2026 | 2026-10-06 | $30M | F-Prime, GV, .406 Ventures, Hims & Hers, Amgen |
Investors
- F-Prime lead
- GV lead
- .406 Ventures lead
- Hims & Hers lead
- Amgen lead
Sources
Last verified:
- https://www.arboretum.bio/news/arboretum-launch
Type: company announcement. Accessed 2026-10-08.
Arboretum launch announcement, datelined Cambridge, Mass. Says the company launched with a $30 million Series A led by F-Prime, GV, .406 Ventures, Hims & Hers, Amgen and other industry leaders, and names partners Advocate Health, Geisinger, Providence Healthcare and Cardiovascular Associates of America. - https://bostonlifesciencestimes.com/2026/10/arboretum-launches-with-30-million-to-expand-precision-medicine-for-common-diseases/
Type: reputable publication. Accessed 2026-10-08.
Boston Life Sciences Times article dated 2026-10-06. Confirms the Cambridge location, the $30 million Series A led by F-Prime, GV, .406 Ventures, Hims & Hers and Amgen, and the four healthcare partners. - https://allsci.com/news/biotech/genomic-medicine-arboretum-lifesciences-launches/
Type: reputable publication. Accessed 2026-10-08.
AllSci article dated 2026-10-07. Confirms the amount, stage and the five lead investors, and says co-founder and CEO Anthony Philippakis is also a general partner at GV. - https://www.finsmes.com/2026/10/arboretum-lifesciences-raises-30m-in-series-a-funding.html
Type: reputable publication. Accessed 2026-10-08.
FinSMEs article dated 2026-10-07. Confirms the Cambridge, MA location and the $30 million Series A, and lists F-Prime, GV, .406 Ventures, Hims & Hers and Amgen as backers without naming a lead.